Odisha Chief Minister Mohan Charan Majhi on Friday, 19 June 2026, marked World Sickle Cell Day by highlighting the state's diagnostic capabilities and urging citizens to support Prime Minister Narendra Modi's national mission to eliminate sickle cell disease by 2047.

Context

World Sickle Cell Day, observed every year on 19 June, is a global health awareness event focused on sickle cell disease — a hereditary blood disorder that disproportionately affects tribal and marginalised communities. In India, the burden is concentrated in states with large Scheduled Tribe populations, including Odisha, Chhattisgarh, Jharkhand, and Madhya Pradesh.

CM Majhi's post claimed that Odisha is 'the only state capable of detecting both sickle cell disease and thalassemia from a single blood sample' — positioning the state as a leader in combined haemoglobinopathy diagnostics. He called on citizens to 'raise awareness and actively support' the Prime Minister's elimination mission.

Policy Backdrop

The National Sickle Cell Anaemia Elimination Mission was launched in July 2023 by Prime Minister Narendra Modi with a target to eliminate the disease by 2047 — the centenary of India's independence. The mission aims to screen approximately 7 crore people across high-burden districts, with integration into existing platforms such as the National Health Mission (NHM) and Ayushman Bharat.

The 2047 elimination goal is embedded within the broader Viksit Bharat (Developed India) development roadmap, linking public health outcomes to the country's long-term socioeconomic ambitions. Sickle cell screening in tribal districts has been a cornerstone of this effort, with states encouraged to pilot faster, combined diagnostic approaches.

Odisha's claim of a dual-detection capability from a single blood sample — covering both sickle cell disease and thalassemia — fits the pattern of states developing combined haemoglobinopathy testing to accelerate national coverage targets, though independent verification of the state's exclusive status in this regard remains pending.

Stakeholders and Impact

Tribal communities in Odisha are the primary stakeholders, as sickle cell disease prevalence is markedly higher among Scheduled Tribe populations. Early and accurate diagnosis through combined screening can reduce the burden of late-stage complications, lower healthcare costs, and enable genetic counselling for at-risk families.

State health departments across high-burden states are watching Odisha's diagnostic model closely. If the single-sample dual-detection approach is validated and scaled, it could inform central procurement and deployment strategies under the National Sickle Cell Anaemia Elimination Mission in the 2025–26 evaluation cycle.

What's Next

Central health authorities are expected to evaluate state-level screening coverage reports and the performance of combined SCD-thalassemia diagnostic kits as part of the mission's ongoing monitoring framework. Odisha's performance data, if independently corroborated, could position the state as a model for replication in other high-burden states.

As the 2047 deadline approaches incrementally, the pressure on states to demonstrate measurable reductions in disease prevalence will intensify. CM Majhi's public endorsement of the national mission on World Sickle Cell Day signals continued political will at the state level to align Odisha's health agenda with the Centre's elimination targets.